ACP 103 reduces haloperidol-induced akathisia and hyperprolactinaemia

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2004年 / 1020卷 / 1期
关键词：
Public Health; Clinical Study; Healthy Subject; Single Dose; Drug Treatment;
D O I：
10.2165/00128415-200410200-00006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [21] HALOPERIDOL-INDUCED NEUROLEPTIC MALIGNANT SYNDROME
    DOSANI, RA
    SOUTHERN MEDICAL JOURNAL, 1983, 76 (04) : 546 - 546
  • [22] Haloperidol-induced isolated lingual dystonia
    Jin, Jeff Wang
    Chapa, Alejandro
    Kockara, Neriman
    Helminiak, Amanda
    BMJ CASE REPORTS, 2021, 14 (10)
  • [23] SEROTONERGIC INVOLVEMENT IN HALOPERIDOL-INDUCED CATALEPSY
    NEALBELIVEAU, BS
    JOYCE, JN
    LUCKI, I
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 265 (01): : 207 - 217
  • [24] Haloperidol-induced torsade de pointes
    O'Brien, JM
    Rockwood, RP
    Suh, KI
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (10) : 1046 - 1050
  • [25] Haloperidol-Induced Ogilvie's Syndrome
    Pierce, Laura
    Ha, Kai
    Katz, Kristina
    James, Penn R.
    Chokhavatia, Sita
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S643 - S643
  • [26] Modulating Role of NO in Haloperidol-Induced Catalepsy
    V. B. Narkevich
    V. D. Mikoyan
    V. G. Bashkatova
    Bulletin of Experimental Biology and Medicine, 2005, 139 : 328 - 330
  • [27] HALOPERIDOL-INDUCED DYSTONIA IN COCAINE ADDICTS
    KUMOR, K
    SHERER, M
    JAFFE, J
    LANCET, 1986, 2 (8519): : 1341 - 1342
  • [28] Gene networks and haloperidol-induced catalepsy
    Iancu, O. D.
    Darakjian, P.
    Malmanger, B.
    Walter, N. A. R.
    McWeeney, S.
    Hitzemann, R.
    GENES BRAIN AND BEHAVIOR, 2012, 11 (01) : 29 - 37
  • [29] BROMOCRIPTINE IN THE TREATMENT OF HALOPERIDOL-INDUCED GALACTORRHEA
    VARIA, IM
    CAVENAR, JO
    TASKA, RJ
    MALTBIE, AA
    NORTH CAROLINA MEDICAL JOURNAL, 1982, 43 (11) : 769 - 770
  • [30] LEARNING IN TOLERANCE TO HALOPERIDOL-INDUCED CATALEPSY
    HINSON, RE
    POULOS, CX
    THOMAS, WL
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1982, 6 (4-6): : 395 - 398
12345